Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
27 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Talphera, Inc.’s names, not what it holds today.
Patents granted
27
27 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
34
since 2001, to Dec 31, 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
'07'08'09'10'11'12'13'14'15'16'17'18'19'20'21
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
AcelRx Pharmaceuticals, Inc. a former name
US, as the owner printed on each patent
32 publishedAcelRx Pharmaceuticals, Inc. a former name
named as the applicant on its applications, in US
2 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Jul 13, 2021 | 11,058,856 | Systems, devices and methods for dispensing oral transmucosal dosage forms | Medical technology | AcelRx Pharmaceuticals, Inc. |
| Jan 19, 2021 | 10,896,751 | Storage and dispensing devices for administration of oral transmucosal dosage forms | Medical technology | AcelRx Pharmaceuticals, Inc. |
| Jul 14, 2020 | 10,709,881 | Apparatus for administering small volume oral transmucosal dosage forms | Medical technology | AcelRx Pharmaceuticals, Inc. |
| Dec 17, 2019 | 10,507,180 | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | Pharmaceuticals | AcelRx Pharmaceuticals, Inc. |
| Jul 9, 2019 | 10,342,762 | Small-volume oral transmucosal dosage forms | Pharmaceuticals | AcelRx Pharmaceuticals, Inc. |
| Apr 2, 2019 | 10,245,228 | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | Pharmaceuticals | AcelRx Pharmaceuticals, Inc. |
| Aug 29, 2017 | 9,744,129 | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | Pharmaceuticals | AcelRx Pharmaceuticals, Inc. |
| May 9, 2017 | 9,642,996 | Methods and apparatus for administering small volume oral transmucosal dosage forms | Medical technology | AcelRx Pharmaceuticals, Inc. |
| Apr 26, 2016 | 9,320,710 | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | Pharmaceuticals | AcelRx Pharmaceuticals, Inc. |
| Mar 22, 2016 | 9,289,583 | Methods for administering small volume oral transmucosal dosage forms using a dispensing device | Medical technology | AcelRx Pharmaceuticals, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| May 20, 2021 | 2021/0151153 | STORAGE AND DISPENSING DEVICES FOR ADMINISTRATION OF ORAL TRANSMUCOSAL DOSAGE FORMS | Medical technology | AcelRx Pharmaceuticals, Inc. · patent 11,676,691 granted from it |
| Jan 23, 2020 | 2020/0022918 | SMALL-VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS | Pharmaceuticals | AcelRx Pharmaceuticals, Inc. |
| May 2, 2019 | 2019/0125659 | SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN | Pharmaceuticals | AcelRx Pharmaceuticals, Inc. · patent 10,507,180 granted from it |
| Jan 24, 2019 | 2019/0027241 | STORAGE AND DISPENSING DEVICES FOR ADMINISTRATION OF ORAL TRANSMUCOSAL DOSAGE FORMS | Medical technology | AcelRx Pharmaceuticals, Inc. · patent 10,896,751 granted from it |
| Aug 30, 2018 | 2018/0243169 | APPARATUS AND METHODS FOR DISPENSING ORAL TRANSMUCOSAL DOSAGE FORMS | Medical technology | AcelRx Pharmaceuticals, Inc. · patent 11,672,738 granted from it |
| Jun 14, 2018 | 2018/0161270 | SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN | Pharmaceuticals | AcelRx Pharmaceuticals, Inc. · patent 10,245,228 granted from it |
| Sep 14, 2017 | 2017/0259051 | APPARATUS FOR ADMINISTERING SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS | Medical technology | AcelRx Pharmaceuticals, Inc. · patent 10,709,881 granted from it |
| Apr 6, 2017 | 2017/0098057 | STORAGE AND DISPENSING DEVICES FOR ADMINISTRATION OF ORAL TRANSMUCOSAL DOSAGE FORMS | Medical technology | AcelRx Pharmaceuticals, Inc. |
| Jul 28, 2016 | 2016/0213606 | SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN | Pharmaceuticals | AcelRx Pharmaceuticals, Inc. · patent 9,744,129 granted from it |
| Jun 23, 2016 | 2016/0175533 | SYSTEMS, DEVICES AND METHODS FOR DISPENSING ORAL TRANSMUCOSAL DOSAGE FORMS | Medical technology | AcelRx Pharmaceuticals, Inc. · patent 11,058,856 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.